Publications by authors named "Markus Leweke"

Claim this Profile
R
Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them.
Oliver D Howes, Bernard R Bukala, Eric Y H Chen, Christoph U Correll, Alkomiet Hasan, F Markus Leweke

Am J Psychiatry· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid metabolomics in autistic regression reveals dysregulation of sphingolipids and decreased β-hydroxybutyrate.
Jingya Yan, Velda X Han, Hannah F Jones, Timothy A Couttas, Beverly Jieu, F Markus Leweke

EBioMedicine· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel youth mental health services in Australia: What differences are being reported about the clinical needs of those who attend and the outcomes achieved?
Ian B Hickie, Sebastian Rosenberg, Joanne S Carpenter, Jacob J Crouse, Blake Hamilton, Markus Leweke

Aust N Z J Psychiatry· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alterations to sphingolipid metabolism from antipsychotic administration in healthy volunteers are restored following the use of cannabidiol.
Beverly Jieu, Eliska B Sykorova, Cathrin Rohleder, Elisabeth Marcolini, Anna E Hoffmann, F Markus Leweke

Psychiatry Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dependent effects of oral cannabidiol and delta-9-tetrahydrocannabinol on serum anandamide and related N-acylethanolamines in healthy volunteers.
Timothy A Couttas, Carola Boost, Franziska Pahlisch, Eliska B Sykorova, Juliane K Mueller, Judith E Leweke, F Markus Leweke

BMJ Ment Health· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabidiol and its Potential Evidence-Based Psychiatric Benefits - A Critical Review.
Inga Dammann, Cathrin Rohleder, F Markus Leweke

Pharmacopsychiatry· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
ReTimeML: a retention time predictor that supports the LC-MS/MS analysis of sphingolipids.
Michael Allwright, Boris Guennewig, Anna E Hoffmann, Cathrin Rohleder, Beverly Jieu, F Markus Leweke

Sci Rep· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EMPOWERED trial: protocol for a randomised control trial of digitally supported, highly personalised and measurement-based care to improve functional outcomes in young people with mood disorders.
Ian B Hickie, Frank Iorfino, Cathrin Rohleder, Yun Ju Christine Song, Alissa Nichles, F Markus Leweke

BMJ Open· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma endocannabinoids in cocaine dependence and their relation to cerebral metabotropic glutamate receptor 5 density.
Sara L Kroll, Lea M Hulka, Ann-Kathrin Kexel, Matthias Vonmoos, Katrin H Preller, F Markus Leweke

Transl Psychiatry· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous Assessment of Serum Levels and Pharmacologic Effects of Cannabinoids on Endocannabinoids and -Acylethanolamines by Liquid Chromatography-Tandem Mass Spectrometry.
Timothy A Couttas, Carola Boost, Franziska Pahlisch, Eliska B Sykorova, Judith E Leweke, F Markus Leweke

Cannabis Cannabinoid Res· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state.
Dagmar Koethe, Cathrin Rohleder, Lutz Kracht, F Markus Leweke

Front Psychiatry· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing the Antipsychotic in Early Nonimprovers to Amisulpride or Olanzapine: Randomized, Double-Blind Trial in Patients With Schizophrenia.
Stephan Heres, Joachim Cordes, Sandra Feyerabend, Christian Schmidt-Kraepelin, Richard Musil, F Markus Leweke

Schizophr Bull· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of adjunctive brexpiprazole on sleep-wake and circadian parameters in youth with depressive disorders: study protocol for a clinical trial.
Joanne S Carpenter, Natalia Zmicerevska, Jacob J Crouse, Alissa Nichles, Alexandra Garland, F Markus Leweke

BMJ Open· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current State of Fluid Lipid Biomarkers for Personalized Diagnostics and Therapeutics in Schizophrenia Spectrum Disorders and Related Psychoses: A Narrative Review.
Timothy A Couttas, Beverly Jieu, Cathrin Rohleder, F Markus Leweke

Front Psychiatry· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Immune Associated Mental Illnesses in Adolescents and Young Adults: Pathophysiological Role and Therapeutic Perspectives.
Richard B Banati, Cathrin Rohleder, F Markus Leweke, Norbert Mueller, Akira Sawa

Front Psychiatry· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A biomarker-authenticated model of schizophrenia implicating NPTX2 loss of function.
Mei-Fang Xiao, Seung-Eon Roh, Jiechao Zhou, Chun-Che Chien, Brendan P Lucey, F Markus Leweke

Sci Adv· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurobiology Youth Follow-up Study: protocol to establish a longitudinal and prospective research database using multimodal assessments for current and past mental health treatment-seeking young people within an early intervention service.
Alissa Nichles, Natalia Zmicerevska, Yun Ju Christine Song, Chloe Wilson, Catherine McHugh, F Markus Leweke

BMJ Open· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Severe Adolescent Major Depressive Syndrome Turns Out to Be an Unusual Case of Anti-NMDA Receptor Encephalitis.
Alexander Moldavski, Holger Wenz, Bettina E Lange, Cathrin Rohleder, F Markus Leweke

Front Psychiatry· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabidiol and Amisulpride Improve Cognition in Acute Schizophrenia in an Explorative, Double-Blind, Active-Controlled, Randomized Clinical Trial.
F Markus Leweke, Cathrin Rohleder, Christoph W Gerth, Martin Hellmich, Ralf Pukrop

Front Pharmacol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neural Autoantibodies in Cerebrospinal Fluid and Serum in Clinical High Risk for Psychosis, First-Episode Psychosis, and Healthy Volunteers.
Christian G Bien, Cathrin Rohleder, Juliane K Mueller, Corinna I Bien, Dagmar Koethe, F Markus Leweke

Front Psychiatry· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers.
Timo Woelfl, Cathrin Rohleder, Juliane K Mueller, Bettina Lange, Anne Reuter, F Markus Leweke

Front Psychiatry· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Youth Mental Health Tracker: protocol to establish a longitudinal cohort and research database for young people attending Australian mental health services.
Cathrin Rohleder, Yun Ju Christine Song, Jacob J Crouse, Tracey A Davenport, Frank Iorfino, F Markus Leweke

BMJ Open· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabidiol as a treatment option for schizophrenia: recent evidence and current studies.
Julie Schoevers, Judith E Leweke, F Markus Leweke

Curr Opin Psychiatry· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic Psychosocial Stress Causes Increased Anxiety-Like Behavior and Alters Endocannabinoid Levels in the Brain of C57Bl/6J Mice.
Yvonne Bouter, Magdalena M Brzózka, Rafal Rygula, Franziska Pahlisch, F Markus Leweke

Cannabis Cannabinoid Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cannabinoids and the endocannabinoid system in anxiety, depression, and dysregulation of emotion in humans.
Verity L Chadwick, Cathrin Rohleder, Dagmar Koethe, F Markus Leweke

Curr Opin Psychiatry· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis